Conference Coverage
Latest News
Dec 08, 2025 | News
KT-621 Produces 98% STAT6 Degradation in AD Patients
High Allergen Content Detected in North American Hotel Toiletries Compared to Europe
Dec 08, 2025
Abeona Initiates First Commercial Treatment of Zevaskyn for RDEB
Dec 08, 2025
DeepSeek-R1 Outperforms ChatGPT-4o in Urticaria Clinical Queries
Dec 08, 2025
Top 5 Articles of the Week: November 30-December 5
Dec 07, 2025
Advertisement
Shorts
0:44
The Key Difference Between Treating Adult and Pediatric Patients
30 minutes ago
by
Patrick Burnett, MD, PhD
0:52
Ethical Dilemmas in Dermatology
3 days ago
by
Heather Goff, MD, MPH
0:34
How Dermatologists Should Guide the Future of Artificial Intelligence
5 days ago
by
Joseph Gatti, DMSc, MPAS, MBA, PA-C
0:26
Why Social Media is the New WebMD
7 days ago
by
Shannon Trotter, DO
0:32
Improving Skin of Color Representation in Training Materials
8 days ago
by
Mondana Ghias, MD, FAAD
0:47
The Future of GLP-1 Usage in Dermatology
10 days ago
by
Joely Kaufman, MD
0:37
Why Complacency is Devastating in Dermatology
12 days ago
by
Rosalyn George, MD
1:30
Derm Dispatch: Live at SDPA Fall 2025
21 days ago
by
Renata Block, DMSc, MMS, PA-C
0:13
Breast Cancer Care by Dermatologists: A Year-Round Commitment
a month ago
by
Christopher G. Bunick, MD, PhD
0:34
Leave the Ladder Down: Mentoring the Next Generation
a month ago
by
Lauren Miller, PA-C(+1 more)
Podcasts
Dermatology Times Digital Edition
Learn more about the in-depth topics covered in the November 2025 print issue of Dermatology Times.
Discover 5 effective tax-saving strategies for investors in dermatology, enhancing portfolio management and planning for 2026 with OJM Group's expert insights.
Maui Derm NP+PA Fall 2025 conference showcases cutting-edge insights in dermatology, featuring expert discussions on skin cancer, atopic dermatitis, and rare dermatoses.
New research reveals ritlecitinib's potential to reverse scarring alopecias by targeting inflammation, offering hope for hair regrowth in autoimmune disorders.
Explore how skin aging and cellular senescence impact overall health, revealing insights into anti-aging strategies and cosmetic conundrums.
Denifanstat emerges as a groundbreaking oral therapy for acne, targeting sebum production and inflammation, promising safer, effective treatment options.
Experts discuss essential skin care strategies for sensitive skin, emphasizing evidence-based cleansing and moisturizing to restore the compromised skin barrier.
Experts discuss effective strategies for managing facial hyperpigmentation, emphasizing personalized treatment plans and the importance of sun protection.
Experts discuss icotrokinra's potential to revolutionize psoriasis treatment with oral therapies, emphasizing efficacy, safety, and patient-centered care at EADV 2025.
In a recent Dermatology Times custom video series, Zoe Diana Draelos, MD, and Cheri Frey, MD, discussed evidence-based cleansing and moisturizing practices for sensitive skin.
Continuing Medical Education
All News
Advertisement
Advertisement
In case you missed it, this week we had news about clascoterone 5% for hair growth improvements, dermatology's role in lung cancer toxicities, IPV in female psoriasis patients, and more.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.
A study reveals high rates of intimate partner violence among women with psoriasis, linking it to poorer quality of life and increased PTSD symptoms.
At a Dermatology Times Case-Based Roundtable event, Joe Gorelick, MSN, FNP-C, reviewed real-world strategies for hidradenitis suppurativa, highlighting growing preference for bimekizumab based on its dual IL-17A/IL-17F inhibition.
Discover the latest insights on laser and energy-based treatments for rosacea, highlighting the effectiveness of radiofrequency microneedling and combination therapies.
Experts explore the integration of AI in atopic dermatitis management, highlighting benefits, risks, and the need for cautious implementation in patient care.
New study reveals how microneedle radiofrequency technology effectively addresses postpartum abdominal skin laxity, enhancing skin elasticity and patient satisfaction.
Selected pieces will be featured in Dermatology Times’ year-end and early-2026 coverage.
InnoCare Pharma has initiated a global trial for soficitinib, targeting prurigo nodularis, aiming to enhance treatment options for this chronic skin condition.
Advertisement
Alpha-9 Oncology's A9-3408 trial targets MC1R in advanced melanoma, offering a novel radiotherapeutic approach beyond traditional treatments.
Dermatology Times has compiled a list of dermatological meetings taking place during the month of December.
Cosmo Pharmaceuticals reveals promising phase 3 results for clascoterone 5% solution, showing significant hair growth improvement in alopecia.
Tori Spelling and Stella McDermott share their journey with eczema, promoting the Free to Be Me campaign and discussing innovative treatments like roflumilast.
At the Horizons in Advanced Practice meeting, Omar Noor, MD, led NP and PA attendees through 3 complex cases of atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
DeepSeek-R1 Outperforms ChatGPT-4o in Urticaria Clinical Queries
5
